Clinical Trials Directory

Trials / Unknown

UnknownNCT03868176

Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cell Tumors

Phase II, Open-label, Randomized, Non-comparative Study Evaluating the Impact of Short Message Service (SMS) on Compliance With Surveillance of Patients With Germ-cell Tumors. (TEXTIS Study)

Status
Unknown
Phase
Study type
Observational
Enrollment
235 (estimated)
Sponsor
Centre Hospitalier Universitaire de Besancon · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the impact of Short Message Service (SMS) on compliance with surveillance of patients with germ-cell tumors. Patients will be randomized in a 2:1 ratio to get 2 groups : (1) patients will receive reminder SMS before appointment detailing the date of consultation and exams to be performed before; (2) standard of care without SMS.

Conditions

Interventions

TypeNameDescription
OTHERshort message serviceshort message service

Timeline

Start date
2019-02-28
Primary completion
2021-08-01
Completion
2021-08-01
First posted
2019-03-08
Last updated
2019-03-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03868176. Inclusion in this directory is not an endorsement.